by David Cassak
Spine instruments and implants are the orthopedic industry's answer to a 20-year overnight success. Today, the market couldn't be hotter,...
As the growth of the spine market outpaces virtually every other orthopedic segment, spine companies are hot. But the challenges that small spine start-ups face aren't only technological; they're also competitive as the market is defined by large spine players and a host of major orthopedic companies looking to tap into spine's potential.
by David Cassak
Spine instruments and implants are the orthopedic industry's answer to a 20-year overnight success. Today, the market couldn't be hotter,...
MedTech Forum 2025 was less MDR-focused than in previous years, as macro issues and exogenous threats were forced further into the center of medtech business thinking.
In a conversation with In Vivo, CEO Jon Congleton discusses Mineralys’s data-rich journey toward an NDA filing, the significance of recent trial wins and how its candidate may offer a dual benefit in blood pressure and renal protection.
Qubit Pharmaceuticals and Sorbonne University launched a quantum AI model that could slash drug synthesis requirements and enable exploration of previously undruggable targets.